-
Mashup Score: 0
GLP-1 receptor agonists provide kidney protection in overweight patients with or without type 2 diabetes.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0
Can HIV patients get a kidney transplant? Yes, a November 2024 update removes all barriers to routine transplant between infected patients.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
As of November 27, 2024, patients with HIV can get a #kidney or liver transplant outside of the research setting, according to an HHS rule update. https://t.co/EySqBUehpU
-
-
Mashup Score: 0Model to Increase Organ Transplant Access to Launch in 2025 - 13 day(s) ago
A new mandatory federal model aims to reduce the kidney transplant shortage by giving incentives for greater donor kidney utilization.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
The Increasing Organ Transplant Access Model, the mandatory model to reduce the #kidney discard rate, will start on July 1, 2025. The mandatory model will give performance-based payments and penalties to participating transplant centers. https://t.co/jTY3wztTkM
-
-
Mashup Score: 0Long-Term Sex Hormone Treatment in Transgender Care Tied to Changes in Body Composition - 13 day(s) ago
Longitudinal changes seen in regional fat and muscle composition and cardiometabolic biomarkers
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Long-term sex hormone treatment in transgender individuals can lead to significant changes in body composition and risk factors for cardiovascular disease. https://t.co/Z4thmhT9s1
-
-
Mashup Score: 0
Zinc deficiency in patients with CKD can increase the risk for disease progression and kidney failure.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Patients with CKD are at elevated risk for zinc deficiency, which has been linked with an increased risk for CKD progression and #kidney failure. https://t.co/lJsEwuCb8a
-
-
Mashup Score: 0American Seniors Struggle to Pay Medical Bills More Than Peers in Other Wealthy Countries - 14 day(s) ago
The survey was conducted between Feb. 29 and June 20, and involved 16,737 interviews of seniors 65 and older.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
American seniors still pay more for health care than their counterparts in most other wealthy countries do, despite coverage by Medicare. https://t.co/mvYS2uozSi
-
-
Mashup Score: 0Model to Increase Organ Transplant Access to Launch in 2025 - 14 day(s) ago
A new mandatory federal model aims to reduce the kidney transplant shortage by giving incentives for greater donor kidney utilization.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
The Increasing Organ Transplant Access Model, the mandatory model to reduce the #kidney discard rate, will start on July 1, 2025. The mandatory model will give performance-based payments and penalties to participating transplant centers. https://t.co/jTY3wztTkM
-
-
Mashup Score: 0Prior Authorization Can Cause Cancer Treatment Delays, Hospitalization, and Death, Survey Suggests - 14 day(s) ago
Prior authorization requirements can be harmful to cancer patients and place additional burdens on medical practices, survey results suggest.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Prior authorization requirements can be harmful to cancer patients and place additional burdens on medical practices, according to survey results released by the American Society for Radiation Oncology (ASTRO). https://t.co/2LVQioNa8s
-
-
Mashup Score: 0Tirzepatide Bests Semaglutide in Head-to-Head Weight Loss Trial - 15 day(s) ago
The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects. Tirzepatide provided superior weight loss when compared with semaglutide in the SURMOUNT-5 trial.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Topline results were announced from a phase 3b clinical trial comparing tirzepatide with semaglutide in obese or overweight participants without type 2 diabetes. https://t.co/fFKVBSDd2t
-
-
Mashup Score: 0
At the 2024 LUGPA annual meeting, Gautam Jayram, MD, reviewed important developments therapeutics and diagnosis and staging.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Therapeutic options to treat intermediate-risk and BCG-unresponsive bladder cancer, such as medications and ablative therapies, are expanding, and novel PET tracers enable improved diagnosis and staging of clear cell renal cell carcinoma. https://t.co/hNwXyS47NB #kcsm
-
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in patients with and without type 2 diabetes. https://t.co/9ANmtApzLH